Industry News - Tag: Teva

You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.

Karo Pharma gains full control of Teva OTC portfolio
Premium

8 February 2021

Sweden’s Karo Pharma is acquiring a portfolio of OTC brands – including the Flux fluoride rinse and Decubal skincare products – from Israel’s Teva for EUR84 million (USD102 million).

Read the full story

Desloratadine set for OTC switch across Europe
Premium

19 October 2020

Teva’s Desloratadine ratiopharm is set to become the sixth medicine to gain non-prescription status through the European Union’s centralised authorisation procedure.

Read the full story

Industry News - Tag: Teva

Karo Pharma gains full control of Teva OTC portfolio Premium

Desloratadine set for OTC switch across Europe Premium

Your privacy

Karo Pharma gains full control of Teva OTC portfolio
Premium

Desloratadine set for OTC switch across Europe
Premium